BTRC and triple-negative breast carcinoma: We generated a triple negative breast cancer (TNBC) cell line, MDA-MB-231 that stably expresses doxycycline (DOX)-inducible shRNA against one of the two β-TrCP isoforms namely β-TrCP1 referred to as MDA-MB-231Δβ-TrCP.